According to the study by Allagoa et al. (2021) from Yale School of Medicine found that screen-detected invasive cancers were more likely to be hormone receptor positive and smaller in size, consistent with our findings on tumor size distribution and ER/PR status. This evidence concerns the gene NR4A1 and neoplasm.